The Amicus Separator’s single-use disposable kit combined with the Phelix Photoactivation Device create an online, closed system to perform photopheresis. The patient remains connected to the Amicus device throughout the procedure. After photoactivation, Amicus reinfuses the treated cells back to the patient.
The Phelix Photoactivation Device is used to provide extracorporeal photoimmunotherapy when used in conjunction with the Amicus ECP System
The Phelix Device promotes safety and performance utilizing multiple sensors to ensure consistent temperature, mixing and UV-A light exposure.
The ECP System is indicated for the palliative treatment of the skin manifestations of cutaneous T-cell lymphoma (CTCL) that is unresponsive to other forms of treatment.
Contact your local Fresenius Kabi representative to learn more about Amicus Blue.
Refer to the Amicus Separator operator's manual for the full list of warnings and cautions associated with the use of the devices.